Rheumatology & Inflammatory

Advancing Arthritis Clinical Research

Arthritis affects millions of people worldwide, causing chronic pain, stiffness, swelling, and reduced mobility. CenExel partners with sponsors to advance innovative therapies for osteoarthritis, rheumatoid arthritis, psoriatic arthritis, and other inflammatory joint conditions through high-quality clinical research and diverse patient populations.

Studies Conducted
0 +
Trial Participants
0 +
Active Sites
0 +
Overview

Leading Arthritis Clinical Research

CenExel delivers specialized expertise in arthritis and inflammatory disease clinical trials through experienced investigators, advanced diagnostic capabilities, and patient-focused recruitment strategies. Our teams support sponsors across early-phase and late-phase rheumatology studies with scientific precision and operational excellence.

Improve Patient Mobility

Our sites support therapies focused on reducing inflammation, improving joint function, and enhancing quality of life for arthritis patients.

Accelerate Trial Performance

CenExel combines rapid enrollment, diverse populations, and experienced rheumatology investigators to support faster study execution.
Conditions Covered

Arthritis Conditions We Research

Our arthritis research programs support a wide range of rheumatologic and inflammatory conditions across adult and aging populations.

  • Rheumatoid Arthritis (RA)
  • Osteoarthritis (OA)
  • Psoriatic Arthritis
  • Ankylosing Spondylitis
  • Juvenile Idiopathic Arthritis
  • Gout
  • Fibromyalgia
  • Lupus-Related Arthritis
Our Approach

Why Sponsors Choose CenExel for Arthritis

CenExel provides sponsors with experienced arthritis research capabilities, diverse patient populations, and operational excellence designed to support successful clinical outcomes.

01

Specialized Rheumatology Teams

Experienced investigators and coordinators with deep expertise in inflammatory and musculoskeletal disorders.

02

Advanced Patient Recruitment

Access to broad patient databases and targeted outreach strategies for arthritis populations.

03

Diverse Patient Populations

Multi-site capabilities help ensure representative patient enrollment across demographics and disease severity.

04

Efficient Trial Execution

Dedicated operational support and streamlined workflows help accelerate study timelines and site performance.

Phase Coverage

Supported Arthritis Trial Phases

CenExel supports arthritis and rheumatology studies from early-stage clinical development through post-market research.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Additional support includes biomarker studies, long-term safety monitoring, pain assessment protocols, and mobility-focused outcome measures.

Arthritis Task Force

CenExel supports arthritis and inflammatory disease studies through experienced investigators, advanced patient recruitment strategies, and specialized rheumatology research sites across the United States.

Active Sites

18 Sites

CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg

Our Blog